In the BioHarmony Drug Report Database

"Preview" Icon

Chlorotrianisene

Tace (chlorotrianisene) is a small molecule pharmaceutical. Chlorotrianisene was first approved as Tace on 1982-01-01. It is used to treat hypogonadism, premature menopause, and prostatic neoplasms in the USA.

 

Trade Name

 

Tace
 

Common Name

 

chlorotrianisene
 

ChEMBL ID

 

CHEMBL1200761
 

Indication

 

hypogonadism, premature menopause, prostatic neoplasms
 

Drug Class

 

Nonsteroidal estrogen

Image (chem structure or protein)

Chlorotrianisene structure rendering